Source link : https://newshealth.biz/health-news/ocrelizumab-may-double-serious-infection-risk-in-ms/
(MedPage Today) — Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS patients, a real-world cohort study showed. The risk for serious infection was higher (OR 1.98, 95… Source link : https://www.medpagetoday.com/meetingcoverage/ectrims/117680 Author : Publish date : 2025-09-28 14:54:00 Copyright for syndicated content belongs to […]
The post Ocrelizumab May Double Serious Infection Risk in MS first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-28 14:54:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8